Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
Johns Hopkins University · with National Institute on Minority Health and Health Disparities (NIMHD), Rutgers University · NCT06128928
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 900
- US sites recruiting
- 1
- Study start
- July 8, 2023
- Record last updated
- November 12, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to find out which approach works better in getting more of the friends and connections of Latino adults get vaccinated against COVID-19.
The main questions this study aims to answer are:
- Can teaching people to use motivational interviewing help more friends and connections of Latino adults get the COVID-19 vaccine compared to just giving information about the vaccine?
- What are the things that make it easier or harder for Latinos and networks to get the COVID-19 vaccine?
- How does this intervention work in practice so that it can be made available to more people in the future
The researchers will compare the vaccine rates of the friends and connections of Latinos who have been trained in motivational interviewing with those who have only been given information about the COVID-19 vaccine. This will help figure out which method works best to encourage more people to get vaccinated.
Being studied: REDES; Control
Conditions: COVID-19; Vaccine
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Eligibility criteria for index participants (eligibility for index participants is intended to select participants who are less vaccine hesitant):
- Age 18 years or older, and
- Self-identifies as Hispanic/Latino, and
- Living in Maryland, and
- Has received at least one COVID-19 vaccine/booster in the last 12 months.
Eligibility criteria for primary and secondary network members (peers):
Eligibility for peers is intended to select for participants who are more vaccine hesitant (e.g. unvaccinated, or have not received at least one COVID-19 vaccine/booster in the last 12 months)
- 18 years old or older, and
- Self-identifies as Hispanic/Latino, and
- Living in Maryland, and
- Provide a study coupon to verify that they were referred by an index or a primary network member, and
- Has not received at least one COVID-19 vaccine/booster in the last 12 months.
Exclusion Criteria
- Previously participated in the study
- Lacks capacity to consent
Recruiting US locations
Johns Hopkins University
Baltimore, MD 21287
Site contact: Kathleen Page, MD · 410-321-0909 · kpage2@jhmi.edu
Study contacts (from the official record)
- Kathleen R Page, MD · (410) 321-0909 · kpage2@jhmi.edu
- Adrianna Moore, MSW · 410-321-0909 · adrianna.moore@jhmi.edu
Similar studies in Maryland
All vaccine studies in Maryland →- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Columbia, MD + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–50
- RecruitingHealthy volunteersPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Baltimore, MD + 4 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–50